Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000618628 | SCV000736053 | uncertain significance | Cardiovascular phenotype | 2017-09-26 | criteria provided, single submitter | clinical testing | The p.R966Q variant (also known as c.2897G>A), located in coding exon 16 of the TTN gene, results from a G to A substitution at nucleotide position 2897. The arginine at codon 966 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000643738 | SCV000765425 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-08-28 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000728296 | SCV000855849 | uncertain significance | not provided | 2017-07-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000728296 | SCV001983015 | likely benign | not provided | 2021-03-30 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000728296 | SCV003819027 | uncertain significance | not provided | 2019-05-13 | criteria provided, single submitter | clinical testing |